Article
PML1-Mediated Feedforward Loop Through PI3K and MAPK Axes Drives Endocrine Resistance
2025-05-16
Abstract excerpt
<h4>ABSTRACT</h4> Treatment of estrogen receptor-positive (ER+) breast cancer is significantly hindered by endocrine resistance. We identified PML1 as a key therapeutic entity that can be targeted to overcome resistance. Endocrine-resistant breast cancer cells share three key characteristics: elevated PML1 protein levels, enhanced activity of PI3K, MAPK, or both signaling pathways, and reduced ER activity. We dev...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5f39a06c-628a-5fbe-b358-ba0d894a298e
- DOI
- 10.1101/2025.05.15.653365
